Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H11NO2 |
| Molecular Weight | 105.1356 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCNCCO
InChI
InChIKey=ZBCBWPMODOFKDW-UHFFFAOYSA-N
InChI=1S/C4H11NO2/c6-3-1-5-2-4-7/h5-7H,1-4H2
| Molecular Formula | C4H11NO2 |
| Molecular Weight | 105.1356 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Diethanolamine (DEA) is an amino alcohol commonly used in the preparation of soaps and surfactants, agricultural chemicals and in textile processing. DEA and DEA-Derivatives are used in other products besides cosmetics and personal care products. For example, DEA and DEA-derivatives have been approved for several food-related applications, primarily food packaging.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Use of high-boiling point organic solvents for pulping oil palm empty fruit bunches. | 2008-04 |
|
| Repeated dose toxicity and developmental toxicity of diisopropanolamine to rats. | 2007-10 |
|
| Biodegradation of novel amino acid derivatives suitable for complexing agents in pulp bleaching applications. | 2007-05-01 |
|
| hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression. | 2007-04-23 |
|
| Diethanolamine alters proliferation and choline metabolism in mouse neural precursor cells. | 2007-04 |
|
| Ternary complexes of flurbiprofen with HP-beta-CD and ethanolamines characterization and transdermal delivery. | 2007-03 |
|
| Determination of occupational exposure to alkanolamines in metal-working fluids. | 2007-03 |
|
| CO2 absorption in aqueous solutions of alkanolamines: mechanistic insight from quantum chemical calculations. | 2007-02-22 |
|
| Regenerating fuel-gas desulfurizing agents by using bipolar membrane electrodialysis (BMED): effect of molecular structure of alkanolamines on the regeneration performance. | 2007-02-01 |
|
| Cholesterol synthesis inhibitors protect against platelet-activating factor-induced neuronal damage. | 2007-01-18 |
|
| Simultaneous monitoring of inorganic cations, amines and amino acids in human sweat by capillary electrophoresis. | 2007-01-02 |
|
| DEA in consumer products is safe. | 2007-01 |
|
| Stimulating effect of Japanese herbal (kampo) medicine, hochuekkito on upper respiratory mucosal immune system. | 2006-12 |
|
| Chemical exposures. Will DEA findings wash? | 2006-11 |
|
| Simultaneous absorption of CO2 and H2S into aqueous blends of N-methyldiethanolamine and diethanolamine. | 2006-10-01 |
|
| Synthesis, structure, and hydrolytic reaction of trans-dichlorobis(diethanolamine-N)palladium(II) with N-acetylated L-histidylglycine dipeptide. | 2006-10 |
|
| Diethanolamine alters neurogenesis and induces apoptosis in fetal mouse hippocampus. | 2006-08 |
|
| Potassium/proton antiport system of Escherichia coli. | 2006-07-21 |
|
| A heterotrimetallic Cu-Co-Zn complex with the 2,2'-iminodiethanol ligand. | 2006-06 |
|
| Diethanolamine and phenobarbital produce an altered pattern of methylation in GC-rich regions of DNA in B6C3F1 mouse hepatocytes similar to that resulting from choline deficiency. | 2006-04 |
|
| The decay of the ATPase activity of light plus thiol-activated thylakoid membranes in the dark. | 2006-02 |
|
| Cloning, functional expression and primary characterization of Vibrio parahaemolyticus K+/H+ antiporter genes in Escherichia coli. | 2006-01 |
|
| P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells. | 2006 |
|
| Impairment of chondrocyte biosynthetic activity by exposure to 3-tesla high-field magnetic resonance imaging is temporary. | 2006 |
|
| Simultaneous determination of inorganic anions and organic acids in amine solutions for sour gas treatment by capillary electrophoresis with indirect UV detection. | 2005-12-30 |
|
| Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action. | 2005-12 |
|
| Determination of novel complexing agents in pulp and paper mill effluents and in lake water by liquid chromatography. | 2005-11-11 |
|
| Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs. | 2005-10-04 |
|
| Ecotoxicological evaluation of diethanolamine using a battery of microbiotests. | 2005-10 |
|
| Species differences in the induction of hepatocellular DNA synthesis by diethanolamine. | 2005-10 |
|
| Investigation of the formation of N-nitrosodiethanolamine in B6C3F1 mice following topical administration of triethanolamine. | 2005-10 |
|
| The allergy adjuvant effect of particles - genetic factors influence antibody and cytokine responses. | 2005-06-21 |
|
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005-06 |
|
| Postnatal development of rat pups after maternal exposure to diethanolamine. | 2005-06 |
|
| Effect of cationic micellar aggregates on the kinetics of oxidation of aminoalcohols by N-bromosuccinimide in alkaline medium. | 2005-05-15 |
|
| Small-angle neutron scattering of ionic perfluoropolyether micellar solutions: role of counterions and temperature. | 2005-05-12 |
|
| Simultaneous detection of monoethanolamine, diethanolamine, and triethanolamine by HPLC with a chemiluminescence reaction and online derivatization to tertiary amine. | 2005-05 |
|
| Percutaneous penetration of diethanolamine through human skin in vitro: application from cosmetic vehicles. | 2005-05 |
|
| Determination of diethanolamine in shampoo products containing fatty acid diethanolamides by liquid chromatography with a thermal energy analyzer. | 2005-04-30 |
|
| Chemical destabilization of oil-in-water emulsion by novel polymerized diethanolamines. | 2005-04-01 |
|
| High-frequency, high-field EPR; magnetic susceptibility; and X-ray studies on a ferromagnetic heterometallic complex of diethanolamine (H2L), [Cu4(NH3)4(HL)4][CdBr4]Br2.3dmf.H2O. | 2005-01-24 |
|
| Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram. | 2005-01-21 |
|
| A functional variant of Fcgamma receptor IIIA is associated with rheumatoid arthritis in individuals who are positive for anti-glucose-6-phosphate isomerase antibodies. | 2005 |
|
| Chemical-induced atrial thrombosis in NTP rodent studies. | 2005 |
|
| Characterization of spontaneous and chemically induced cardiac lesions in rodent model systems: the national toxicology program experience. | 2005 |
|
| Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. | 2005 |
|
| Evaluation of alkaline phosphatase activity assay for the Reflotron system after substitution of the comparison method. | 2005 |
|
| Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. | 2005 |
|
| The effect of ovary implants on juvenile hormone production by corpora allata of male Diploptera punctata. | 2003 |
|
| The development of photometric sensors for boronic acids. | 2001-10 |
Patents
Sample Use Guides
MICE: Groups of 50 male and 50 female mice were administered 0, 40, 80, or 160 mg diethanolamine/kg body weight in ethanol dermally for 2 years. In male mice, the incidences of hepatocellular adenoma and of hepatocellular adenoma or carcinoma (combined) in all dosed groups and of hepatocellular carcinoma and hepatoblastoma in 80 and 160 mg/kg males were significantly increased compared to the vehicle controls.
Route of Administration:
Other
Sperm suspension was incubated with different concentrations (100–500 ug/mL) of diethanolamine to evaluate sperm parameters such as sperm motility, sperm viability and sperm morphology. diethanolamine caused significant decrease in sperm motility and sperm viability which was concentration and time–dependent.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:41:29 GMT 2025
by
admin
on
Wed Apr 02 08:41:29 GMT 2025
|
| Record UNII |
AZE05TDV2V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 176.170
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000079573
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
924
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
1192808
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
C020283
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
DIETHANOLAMINE
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
28123
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
DTXSID3021932
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
244
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
4959
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
C76748
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
AZE05TDV2V
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
m4388
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | Merck Index | ||
|
AZE05TDV2V
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
CHEMBL119604
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
8113
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
111-42-2
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
203-868-0
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
SUB13571MIG
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | |||
|
1362911
Created by
admin on Wed Apr 02 08:41:29 GMT 2025 , Edited by admin on Wed Apr 02 08:41:29 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (GC)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
